AGS: Beers Criteria for Potentially Inappropriate Med Use in Older Adults Updated
Over 1400 clinical trials and research studies were reviewed by a panel of 13 experts to develop the new guideline.
Over 1400 clinical trials and research studies were reviewed by a panel of 13 experts to develop the new guideline.
Currently, there are no approved therapies for the treatment of MSA, a rare progressive neurodegenerative disease.
The Mediterranean diet was ranked as the best diet overall for 2019.
A recent report from the CDC identified the 10 drugs most frequently mentioned in overdose deaths.
Positive topline results were announced from a Phase 3 trial evaluating the safety and efficacy of rimegepant Zydis orally dissolving tablet for the acute treatment of migraine.
In animal studies, the treatment was associated with improvement in both motor and cognitive function.
According to a Phase 3b open-label study, Ocrevus may interfere with the effectiveness of non-live vaccines.
The FDA has issued a safety communication regarding the risks associated with implanted pumps for intrathecal administration of pain medications.
The authors found that the compounds known as phenylindanes inhibited the aggregation of the amyloidgenic proteins beta-amyloid and tau.
The Food and Drug Administration (FDA) approved the treatment in June 2018, making it the first prescription pharmaceutical formulation of highly-purified, plant-derived cannabidiol, as well as the first treatment indicated for patients with Dravet syndrome.